Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.87%
#2 Biconomy Biconomy +19.56%
#3 MiL.k Alliance MiL.k Alliance +17.80%
#4 THORChain THORChain +17.68%
#5 Wrapped STX (Velar) Wrapped STX (Velar) +16.45%
#6 Gigachad Gigachad +16.31%
#7 Bless Bless +15.32%
#8 The Black Bull The Black Bull +14.68%
#9 MetaDAO MetaDAO +13.65%
#10 XPIN Network XPIN Network +13.17%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Structure Therapeutics Inc. Structure Therapeutics Inc.

Structure Therapeutics Inc.

GPCR
Classement en actions #5250
Structure Therapeutics Inc., an international biopharmaceutical company... Structure Therapeutics Inc., an international biopharmaceutical company currently in its clinical development phase, is committed to creating and providing groundbreaking oral therapies for various chronic diseases that lack adequate treatment options. The company's primary investigational drug, GSBR-1290, is an orally administered, biased small molecule agonist designed to target the glucagon-like-peptide-1 receptor (GLP-1R). This G-protein-coupled receptor (GPCR) is a recognized and validated therapeutic target for managing both type-2 diabetes mellitus and obesity. Furthermore, Structure Therapeutics is developing other oral small molecule treatments that act on different GPCRs, addressing pulmonary and cardiovascular conditions. For example, ANPA-0073 is a biased agonist aimed at the apelin receptor, a GPCR linked to diseases like idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension. Another compound in their pipeline is LTSE-2578, an oral small molecule that acts as a lysophosphatidic acid 1 receptor antagonist, also being explored for the treatment of IPF. Established in 2016, the company was formerly known as ShouTi Inc. and is headquartered in South San Francisco, California.
Prix de l'action
$49.68
Dernière synchronisation: 2026-08-26
Capitalisation boursière
$2.86B
Changement (1 jour)
-0.48%
Changement (1 an)
161.47%
Pays
US
Échange Structure Therapeutics Inc. (GPCR)

Catégorie

Healthcare
Revenus pour Structure Therapeutics Inc. (GPCR)
Revenus en Aug 2026 TTM : 0
Selon les derniers rapports financiers de Structure Therapeutics Inc., le chiffre d'affaires actuel de l'entreprise (TTM) est de 0. En 2026, l'entreprise a réalisé un chiffre d'affaires de 0 égal à le chiffre d'affaires de l'année 2026, qui était de 0. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Structure Therapeutics Inc. de 2026 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
Pas assez de données pour les dates fournies.
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH